AAA Rupture Risk Estimation
Estimates annual rupture risk of abdominal aortic aneurysm (AAA) based on diameter. Guides surveillance and surgical planning.
Score interpretation
→ USS surveillance: 3cm 5-yearly, 4cm 1-yearly; smoking cessation; BP control; statin; no urgent intervention
→ 3-monthly USS; vascular surgery outpatient assessment; EVAR or open repair planning; optimise cardiovascular risk; anaesthetic assessment
→ Symptomatic: same-day vascular surgery admission; suspected rupture: emergency resuscitation and immediate transfer to vascular centre; 2 large-bore IV, O-negative blood, CT only if haemodynamically stable
Interpretation bands for the AAA Rupture Risk. Apply clinical judgement and local guidance.
References
Related
Curated clinical cross-links plus same-class fallbacks.
- Ertapenem · Carbapenem — ESBL / Complicated Intra-Abdominal / Community OPAT
- Tigecycline · Glycylcycline — MDR Gram-Negative / Polymicrobial / Complicated Intra-abdominal
- Bevacizumab (Intravitreal) · Anti-VEGF (Vascular Endothelial Growth Factor Inhibitor)
- Palivizumab · RSV Prophylaxis — Monthly Monoclonal Antibody (High-Risk Infants)
- Ziprasidone · Atypical Antipsychotic — D2/5-HT2A Antagonist (Low Metabolic Risk)
- Atorvastatin (CKD Cardiovascular Risk) · Cardiovascular Risk in CKD
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.